Moreno-Delgado D, Puigdellívol M, Moreno E, Rodríguez-Ruiz M, Botta J, Gasperini P, Chiarlone A, Howell LA, Scarselli M, Casadó V, Cortés A, Ferré S, Guzmán M, Lluís C, Alberch J, Canela EI, Ginés S, McCormick PJ

Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntingtons disease.

Elife. 2020 Jun 9;9:e51093

DOI: 10.7554/eLife.51093